Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-033902
Filing Date
2015-04-14
Accepted
2015-04-14 10:38:57
Documents
1
Period of Report
2015-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3499
  Complete submission text file 0001209191-15-033902.txt   4900
Mailing Address AMGEN INC ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BONANNI FABRIZIO (Reporting) CIK: 0001183903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37347 | Film No.: 15768428

Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations